Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT02218996

Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics

The purpose of this study is to examine the content of the treatment being delivered for anxiety disorders for children and adolescents in the regular outpatient clinics in western Norway. The study will also collect data before and after treatment to evaluate the result of the treatment. Furthermore, as part of the study we aim to collect normative data on two questionnaires used to identify anxiety symptoms and the extent to which anxiety interfere with daily functioning. We also aim to develop a quality indicator for anxiety treatment that can be used to monitor treatment in the regular outpatient service, based on the results of the current study.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Anxiety Disorders Mental Disorders

Age range

7 year–17 year

Sex eligibility

All sexes

Study type

Observational

Primary location

BUPA Helse Stavanger

Stavanger, Rogaland, 4011, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of an anxiety disorder (including PTSD and OCD) based on the diagnostic interview ADIS (ADIS-C/P; Silverman & Albano, 1996).
  • The anxiety disorder is the patients primary diagnosis.
  • Informed concent is given.

Exclusion criteria

  • The patient is in need for other primary treatment intervention (e.g., psychosis, suicidality risk)

Treatment and study plan

Psychosocial treatment

Other

Regular psychosocial treatment in clinical outpatient service.

Primary outcomes

  1. The Anxiety Disorder Interview Schedule for Diagnostic and Statistical Manual (DSM-IV), child and parent versions (ADIS- C/P; Silverman & Albano, 1996).

    Time frame: The primary outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.

    Diagnostic interview for anxiety disorders and other comorbid disorders. For the 10-year follow-up we anticipate to use another version of the diagnostic interview schedule based on revised diagnostic criteria for anxiety disorders.

Secondary outcomes

  1. Children's Anxiety Life Interference Scale (CALIS; Lyneham et al., 2013)

    Time frame: This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).

  2. The Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al., 1999).

    Time frame: This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).

  3. Spence Children's Anxiety Scale (SCAS; Spence, 1998)

    Time frame: This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks).

  4. The Strengths and Difficulties Questionnaire (SDQ; Goodman, 1997)

    Time frame: This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks)

  5. Short Mood & Feeling Questionaire (SMFQ; Angold et al., 1995).

    Time frame: This outcome measure will be administered pre-treatment and post treatment (an expected average of 20 weeks)

  6. Clinical Global Impressions (CGI; Guy, 1976).

    Time frame: The outcome measure will be administered pre-treatment, post treatment (an expected average of 20 weeks) and at ten year follow-up.

Sponsors and collaborators

Lead sponsor

Helse Stavanger HF

Other Gov

Collaborators

  • Helse Vest

Registry information

Official study title

Treatment of Anxiety Disorders for Children and Adolescents in Regular Outpatient Clinics (TADCAROC)

Acronym: TADCAROC

Important dates

Study start
2014
Primary completion
2028
Study completion
2029
First posted
Aug 18, 2014
Registry last updated
Dec 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.